medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2005, Número 2

<< Anterior Siguiente >>

Dermatología Cosmética, Médica y Quirúrgica 2005; 3 (2)


Efectos adversos de itraconazol y terbinafina. Presentación de dos casos y breve revisión de la literatura

Fernández S, Arenas R, Domínguez-Soto L

Idioma: Español
Referencias bibliográficas: 25
Paginas: 92-95
Archivo PDF: 157.74 Kb.


RESUMEN

Presentamos dos casos de reacción a drogas, uno por terbinafina y otro por itraconazol, ambas mujeres, con dermatosis diseminadas a todos los segmentos corporales y caracterizadas por erupción morbiliforme y urticarial. El informe de estos casos debería ser parte de la vigilancia farmacológica.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Katz HI. Drug interactions of the newer oral antifungal agents. Br J Dermatol 1999; 141 suppl 56: 26-32

  2. Texeira F, Arenas R. Interacciones medicamentosas en el tratamiento de las onicomicosis con itraconazol o fluconazol. Dermatología Rev Mex 1996; 40 (5): 340-344

  3. Gupta AK, Shear NH. A risk–benefit assessment of the newer oral antifungal agents used to treat onychomycosis. Drug Saf 2000; 22 (1): 33-52

  4. Johnstone D, Berger C, Fleckman P. Acute fulminant hepatitis after treatment with rabeprazole and terbinafine. Arch Intern Med 2001; 161 (13): 1677-1678

  5. Agarwal K, Manas DM, Hudson M. Terbinafine and fulminant hepatic failure. N Engl J Med 1999; 340 (16): 1292-1293

  6. Nores JM, Biacabe B, Bonfils P. Olfatory disorders due to medications: análisis and review of the literature. Rev Med Intern 2000; 21 (11): 972-977

  7. Schmutz JL, Barbaud A, Trechot P. Terbinafine-induced persistent agueusia: first reported case. Ann Dermatol Venereol 2000; 127 (3): 341

  8. Duxbury AJ, Oliver RJ, Pemberton MN. Persistent impairment of taste associated with terbinafine. Br Dent J 2000; 188 (6): 295-296

  9. Langers AM, Jonkers GJ. Pancreatitis ascribed to the use of itraconazole. Ned Tijdschr Geneeskd 2001; 145 (23): 1127-1128

  10. Castellsague J, García-Rodríguez L, Duque A et al. Risk of serious skin disorders among users of oral antifungals: a population-based study. BMC Dermatology 2002, 2: 14

  11. Taberner R, Puig L, Gilaberte M et al. Acute generalized exanthematous pustulosis induced by terbinafine. Eur J Dermatol 2003; 13 (3): 313-314

  12. Ghislain PD, Ghislain E. Fixed drug eruption due to fluconazole: a third case. J Am Acad Dermatol 2000; 42 (5 Pt 2): 883-884.

  13. Lane JE, Buckthal J, Davis LS. Fixed drug eruption due to fluconazole. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95 (2): 129-130

  14. Weiss JM, Mockenhaupt M, Schopf E et al. Reproducible drug exanthema to terbinafine with characteristic distribution of baboon syndrome. Hautarzt 2001; 52 (12): 1104-1106

  15. Martínez-Alonso JC, Domínguez-Ortega FJ, Fuentes-Gonzalo MJ. Urticaria and angioedema due to itraconazole. Allergy 2003; 58 (12): 1317-1318

  16. Alsadhan A, Taher M, Krol A. Acute generalized exanthematous pustulosis induced by oral fluconazole. J Cutan Med Surg. 2002; 6 (2): 122-124

  17. Fabre B, Albes B, Belhadjali H et al. Acute generalized exanthematous pustulosis due to fluconazole. Ann Dermatol Venereol 2002; 129 (3): 294-297

  18. Saissi EH, Beau-Salinas F, Jonville-Bera AP et al. Drugs associated with acute generalized exanthematic pustulosis. Ann Dermatol Venereol 2003; 130 (6-7): 612-618

  19. Lombardo M, Cerati M, Pazzaglia A. Acute generalized exanthematous pustulosis induced by terbinafine. J Am Acad Dermatol 2003; 49 (1): 158-159

  20. Hill VA, Chow J, Cowley N et al. Subacute lupus erythematosus-like eruption due to terbinafine: report of three cases. Br J Dermatol 2003; 148 (5): 1056

  21. Aksakal BA, Ozsoy E, Arnavut O et al. Oral terbinafine-induced bullous pemphigoid. Ann Pharmacother 2003; 37 (11): 1625-1627

  22. Álvarez-Fernández JG, Castaño Suárez E, Cornejo-Navarro P et al. Photosensitivity induced by oral itraconazole. J Eur Acad Dermatol Venereol 2000; 14 (6): 501-503

  23. Callen JP. Drug-induced cutaneous lupus erythematosus, a distinct syndrome that is frequently unrecognized. J Am Acad Dermatol 2001; 45 (2): 315-316

  24. Szepietowski JC. Terbinafine exacerbates psoriasis: case report with a literature review. Acta Dermatovenereol Croat 2003; 11 (1): 17-21

  25. Ghislain P. Fixed drug eruption due to fluconazole; a third case. J Am Acad Dermatol 2002; 46 (3): 467




2020     |     www.medigraphic.com